Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-01-28 | 2021-05-20 | 132652 |
ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190722 |
ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116699 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-11-18 | 2021-12-23 | 149588 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142172 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190719 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2020-05-29 | 2020-06-18 | 116138 |
ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195466 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-01-15 | 2021-05-20 | 131673 |
ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-12-03 | 2021-05-20 | 129530 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2020-12-03 | 2020-12-17 | 129520 |
ACT PRAMIPEXOLE | 1.5MG | TABLET | Actual shortage | 2024-11-08 | 2025-04-24 | 242361 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2021-06-10 | 2021-09-02 | 140660 |
ACT PRAMIPEXOLE | 1MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195127 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195582 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2020-09-24 | 2020-11-19 | 125001 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-10-26 | 2024-01-11 | 208260 |
ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Resolved | 2019-10-24 | 2020-05-14 | 97147 |
ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Resolved | 2021-11-18 | 2025-04-29 | 149602 |
ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-04-10 | 2020-10-22 | 111838 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
TEVA-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255821 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
TEVA-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117529 |
TEVA-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117526 |
TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |